Pegloticase
Description
Pegloticase, a recombinant uricase enzyme, offers a revolutionary treatment approach for patients suffering from chronic gout, a debilitating condition characterized by recurrent painful attacks due to elevated uric acid levels in the blood. This gene-based therapy works by efficiently breaking down uric acid, effectively reducing its levels and preventing further gout flares. While pegloticase has shown remarkable efficacy in managing severe gout, its effectiveness can vary among individuals, and the therapy comes with potential side effects, emphasizing the importance of careful patient selection and close monitoring.
Associated Diseases
Did you know?
Pegloticase is derived from the uricase enzyme found in certain animals like great apes, but not in humans.
